EFPIA - European Federation of Pharmaceutical Industries and Associations

#Imagine if Europe found the treatment to slow Alzheimer’s progression, produced the first vaccine for brain cancer or medicines that could transform the lives of patients with chronic disease. Now we've imagined. Let's take action: https://shorturl.at/cCGVZ #WeWontRest

Where does #medical #innovation come from? Everything starts with #patients’ #unmet medical #needs. The first step for researchers is to understand how any new therapy could address a problem that is not covered by existing treatments. Hear more from Lundbeck colleagues Jose Luis Molinuevo, Johannes Streffer, Magdalena Jayatissa and Agathe Le Lay as they share why embracing a broad definition of unmet need is essential to delivering what matters to patients: https://lnkd.in/dZQqHajp #WeWontRest

Non-communicable diseases are placing an increasing strain on EU health systems, driving up costs and shortening life expectancy. A new report highlights that investing in #prevention and #treatment saves lives and yields significant economic benefits. https://lnkd.in/dctBmRAn

Today marks a significant step forward in Chiesi’s journey to ensure patients' health and sustainable healthcare solutions. Just a few months after the inauguration of our Biotech Center, we are excited to announce a €430 million investment in Nerviano, Northern Italy, to build a cutting-edge manufacturing facility. The plant will be primarily dedicated to manufacturing carbon-minimal inhalers, dry powder inhalers and sterile biological products. In line with our goal to achieve Net-Zero emissions by 2035, we’re not building a new plant but transforming a historic industrial site into a next-generation manufacturing hub, equipping it with state-of-the-art laboratories and a self-sufficient photovoltaic park. By 2029, the new site will create hundreds of highly skilled jobs, welcoming new talents to our team as we continue shaping the future of healthcare. Learn more: https://lnkd.in/dUjPEZhq #ChiesiGroup #Innovation

Join us next week for a webinar organised in partnership with the EMA and other industry stakeholders! This session, will explore how EMA assessment outputs can support regulatory reliance pathways, helping to streamline the approval of variations (CMC, clinical/safety) efficiently and sustainably. ➡️ Find out more & register here https://lnkd.in/eWPJDZey

The European Diabetes Forum understands the importance of #adherence in the management of #chronic diseases. The right #treatment plan and lifestyle changes can lead to a fuller and healthier life and reduce the risk of #complications. 👏 That is why today we are happy to endorse the first #WorldAdherenceDay! 🩵 🤝 As highlighted in our Community Pledge, with the right #guidance, #treatment and peer #support, people with #diabetes can be empowered to manage their #condition and flourish as fully productive and participating members of society. It is key to treat them as equals in both care and regulatory processes for the best health #outcomes and #quality of life. World Heart Federation #DontMissaMoment #HealthcareAdherence European Association for the Study of Diabetes e.V. (EASD) Breakthrough T1D Société Francophone du Diabète (SFD) International Diabetes Federation Europe PCDE International Society for Pediatric and Adolescent Diabetes (ISPAD) EDENT1FI JACARDI

📣 Today is #WorldAdherenceDay! Did you know good adherence can reduce long-term mortality risk by 21%? Here are some simple ways we can better support patient adherence: ✔️ Align healthcare plan to fit patients lifestyle, preferences and values  ✔️ Simplify instructions and use clear communication ✔️ Stay connected through regular follow-ups ✔️ Provide resources and tools to help with adherence such as our free medication tracker, which you can find here: https://lnkd.in/deptWCQh Together we can help patients stay committed to their healthcare plans and protect the moments that matter most. #DontMissAMoment

Pirms #EPSCO sanāksmes produktīva saruna ar @EFPIA un vairāku 🇪🇺valstu veselības ministriem. 💊Sarunā uzsvēru🇱🇻 pozīciju- ES pilsoņiem jābūt vienlīdzīgai pieejai zālēm. Jo sevišķi inovatīvajiem medikamentiem mazākās ES valstīs - gan nepieciešamajā apjomā, gan par pieejamu cenu.

È una fase cruciale per l'industria del farmaco europea, che ha vissuto una progressiva perdita di competitività in un mondo che è cambiato senza che il vecchio continente si dotasse degli giusti strumenti per stare al passo. Il rapporto Draghi ha evidenziato questo aspetto mesi fa. La rapida attuazione delle raccomandazioni delineate nel rapporto sarà fondamentale. Ma di cosa ha bisogno l'industria farmaceutica europea per riacquistare e mantenere la sua forza, anche di fronte alle sfide geopolitiche attuali? 1)    Primo, mantenere e rafforzare nell’attuale revisione della legislazione farmaceutica la protezione dei dati (RDP), una forma importantissima di proprietà intellettuale. 2)    Delle misure per sviluppare un ecosistema di sperimentazioni armonizzato e agile che supporti studi clinici multi-paese. 3)    Infine, serve rafforzare l’accesso al capitale, in particolare per le PMI, aziende che spesso lavorano all'avanguardia della ricerca medica. EFPIA - European Federation of Pharmaceutical Industries and Associations su: https://lnkd.in/eM-w7JeN.

🌟 Excited to share my interview with Pharma Fakten about our planned Berlin Center for Gene and Cell Therapies! We discussed how Bayer and Charité - Universitätsmedizin Berlin are joining forces to accelerate the #translation of groundbreaking #GCT #research into benefits for #patient faster. The goal is to foster innovation by providing infrastructure and expertise to support startups and enhance Germany's biotech landscape. Check out the full article for more insights! #GeneTherapy #CellTherapy #Biotech #Innovation #Healthcare